🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

American Well Corp executive sells shares worth over $29k

Published 06/06/2024, 06:54 am
AMWL
-

American Well Corp (NYSE:AMWL) President of International, Phyllis Gotlib, has recently sold a total of 71,455 shares of the company's Class A Common Stock, with the transaction amounting to over $29,625. This sale was carried out at a price of $0.4146 per share.

The transaction, dated June 3, 2024, was made to cover tax liabilities arising from the vesting and settlement of restricted stock units on June 1, 2024. According to a footnote in the SEC filing, these sales were executed through an automatic "sell to cover" transaction, which indicates that the sales were not discretionary trades by Gotlib.

Following the transaction, Gotlib still holds a significant number of shares in the company, with a reported 2,383,655 shares of Class A Common Stock remaining in direct ownership. Additionally, an indirect holding of 1,285,011 shares is listed, owned by her husband.

The filing, which was signed by attorney-in-fact Bradford Gay on behalf of Phyllis Gotlib, provides transparency into the executive's stock transactions in compliance with SEC regulations. American Well Corp, headquartered in Boston, MA, operates in the business services sector and is incorporated in Delaware.

Investors often monitor insider transactions as they can provide insights into an executive's view of the company's current valuation and future prospects. However, in this case, the transaction appears to be a routine financial matter related to the vesting of restricted stock units rather than a reflection of the executive's outlook on the company's performance.

In other recent news, American Well Corp. (Amwell) reported a 7% decrease in total revenue year-over-year for the first quarter of 2024, totaling $59.5 million. Despite this, Amwell outlined a strong start to the year, focusing on expanding its digital care enablement and the success of its Converge platform. The company expects a shift towards subscription software to drive gross margin expansion and has projected revenue growth and improved adjusted EBITDA for 2025.

In addition, Piper Sandler maintained a neutral stance on Amwell, following a recent demonstration of the company's behavioral health solution at the Defense Health Agency (DHA). The firm acknowledged the positive developments with Amwell's Converge migrations, which could present an opportunity for the company to secure high incremental gross margin software revenues as the DHA continues its multi-product rollout.

These are some of the recent developments concerning Amwell. The company's engagement with the DHA underscores its efforts to expand its presence within the healthcare solutions sector, particularly in behavioral health. Piper Sandler's neutral rating reflects a wait-and-see approach, requiring further evidence of Amwell's financial performance and growth trajectory.

InvestingPro Insights

As American Well Corp (NYSE:AMWL) navigates the challenging landscape of the business services sector, recent insider transactions have caught the attention of investors. The sale of shares by President of International, Phyllis Gotlib, was a significant event, but it's also crucial to consider the broader financial context of the company as revealed by InvestingPro metrics and tips.

InvestingPro data indicates that AMWL holds a market capitalization of $118.59 million, reflecting the company's current valuation in the market. However, the company's P/E ratio stands at -0.34, with an adjusted P/E ratio for the last twelve months as of Q1 2024 at -0.46, suggesting that investors are cautious about the company's earnings potential. Additionally, AMWL's price/book ratio as of the same period is 0.29, which may indicate that the stock is undervalued relative to its assets.

One of the key InvestingPro Tips to consider is that AMWL holds more cash than debt on its balance sheet, which could provide a cushion against financial headwinds. Yet, it's also important to note that the company is quickly burning through cash and analysts do not anticipate AMWL to be profitable this year. This aligns with the recent insider transaction, which may not necessarily reflect the company's performance but does highlight the importance of understanding the company's cash flow situation.

For investors looking to delve deeper into the financial health and future prospects of American Well Corp, additional insights are available. There are 11 more InvestingPro Tips for AMWL, which can be accessed at https://www.investing.com/pro/AMWL. Readers interested in an in-depth analysis can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, offering a more comprehensive understanding of the company's position and potential trajectory.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.